Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Precision cancer genome testing needs proficiency testing involving all stakeholders.
Maekawa M, Taniguchi T, Nishio K, Sakai K, Matsushita K, Nakatani K, Ishige T, Ikejiri M, Nishihara H, Sunami K, Yatabe Y, Hatanaka KC, Hatanaka Y, Yamamoto Y, Fukuyama K, Oda S, Saito K, Yokomura M, Kubo Y, Sato H, Tanaka Y, Fuchioka M, Yamasaki T, Matsuda K, Kurachi K, Funai K, Baba S, Iwaizumi M. Maekawa M, et al. Among authors: fukuyama k. Sci Rep. 2022 Jan 27;12(1):1494. doi: 10.1038/s41598-022-05589-x. Sci Rep. 2022. PMID: 35087199 Free PMC article.
BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer.
Kondo T, Kanai M, Matsubara J, Quy PN, Fukuyama K, Yamamoto Y, Yamada T, Nishigaki M, Minamiguchi S, Takeda M, Nishio K, Matsumoto S, Muto M. Kondo T, et al. Among authors: fukuyama k. Pancreas. 2020 Nov/Dec;49(10):e101-e103. doi: 10.1097/MPA.0000000000001672. Pancreas. 2020. PMID: 33017331 Free PMC article. No abstract available.
Prevalence of pathogenic germline variants in the circulating tumor DNA testing.
Yamamoto Y, Fukuyama K, Kanai M, Kondo T, Yoshioka M, Kou T, Quy PN, Kimura-Tsuchiya R, Yamada T, Matsumoto S, Kosugi S, Muto M. Yamamoto Y, et al. Among authors: fukuyama k. Int J Clin Oncol. 2022 Oct;27(10):1554-1561. doi: 10.1007/s10147-022-02220-x. Epub 2022 Jul 23. Int J Clin Oncol. 2022. PMID: 35870019 Free PMC article.
Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.
Kondo T, Matsubara J, Quy PN, Fukuyama K, Nomura M, Funakoshi T, Doi K, Sakamori Y, Yoshioka M, Yokoyama A, Tamaoki M, Kou T, Hirohashi K, Yamada A, Yamamoto Y, Minamiguchi S, Nishigaki M, Yamada T, Kanai M, Matsumoto S, Muto M. Kondo T, et al. Among authors: fukuyama k. Cancer Sci. 2021 Jan;112(1):296-304. doi: 10.1111/cas.14674. Epub 2020 Nov 21. Cancer Sci. 2021. PMID: 33007138 Free PMC article.
Inter-assay variability of next-generation sequencing-based gene panels.
Quy PN, Fukuyama K, Kanai M, Kou T, Kondo T, Yoshioka M, Matsubara J, Sakuma T, Minamiguchi S, Matsumoto S, Muto M. Quy PN, et al. Among authors: fukuyama k. BMC Med Genomics. 2022 Apr 15;15(1):86. doi: 10.1186/s12920-022-01230-y. BMC Med Genomics. 2022. PMID: 35428255 Free PMC article.
Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay.
Quy PN, Kanai M, Fukuyama K, Kou T, Kondo T, Yamamoto Y, Matsubara J, Hiroshima A, Mochizuki H, Sakuma T, Kamada M, Nakatsui M, Eso Y, Seno H, Masui T, Takaori K, Minamiguchi S, Matsumoto S, Muto M. Quy PN, et al. Among authors: fukuyama k. Oncologist. 2019 Dec;24(12):e1401-e1408. doi: 10.1634/theoncologist.2018-0587. Epub 2019 Jun 11. Oncologist. 2019. PMID: 31186376 Free PMC article.
550 results